ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1081–1092 of 2020 project topics
HLA Associations with Drug Hepatotoxicity
Identifying HLA alleles predisposing to drug-induced liver injury for specific medications for developing pre-prescription genetic screening tests.
Genetic Factors in Drug-Induced Liver Injury Click to view more details →
Metabolizing Enzyme Variants in DILI Risk
Investigating CYP and UGT enzyme genetic variants affecting drug bioactivation and detoxification for understanding individual DILI susceptibility.
Genetic Factors in Drug-Induced Liver Injury Click to view more details →
DILI GWAS in Large Patient Cohorts
Conducting genome-wide association studies in drug-induced liver injury cases for identifying novel genetic risk factors beyond HLA associations.
Genetic Factors in Drug-Induced Liver Injury Click to view more details →
Mitochondrial Genetic Factors in DILI
Studying mitochondrial DNA variants and nuclear-encoded mitochondrial gene polymorphisms affecting susceptibility to mitochondrial DILI mechanisms.
Genetic Factors in Drug-Induced Liver Injury Click to view more details →
Pharmacogenomic Testing Platform for Drug-Induced Liver Injury Prediction
A clinical-grade SaaS platform that integrates patient genetic profiles with DILI risk algorithms to predict hepatotoxicity before drug administration. Enables pharmaceutical companies and healthcare providers to reduce adverse events, accelerate drug approvals, and optimize patient stratification for precision medicine programs.
Genetic Factors in Drug-Induced Liver Injury Click to view more details →
Ion Channel Gene Variant Database for Hepatotoxicity Risk Assessment
A curated commercial database that catalogs ion channel genetic polymorphisms linked to drug-induced liver injury susceptibility and severity. Provides drug developers and diagnostic labs a comprehensive resource for in silico screening and biomarker discovery, generating licensing and subscription revenue.
Genetic Factors in Drug-Induced Liver Injury Click to view more details →
AI-Powered Genetic Risk Scoring Engine for DILI Susceptibility Stratification
An enterprise software tool that combines machine learning with rare genetic variants to generate personalized DILI risk scores for individual patients. Delivers value through improved clinical trial recruitment, reduced dropout rates, and premium pricing for pharmaceutical companies seeking competitive safety advantages.
Genetic Factors in Drug-Induced Liver Injury Click to view more details →
Genetic Biomarker Panel Development Service for Drug Safety Certification
A contract research service that identifies and validates proprietary genetic markers associated with drug-specific hepatotoxicity for pharmaceutical clients. Generates revenue through service fees, licensing agreements, and co-development partnerships that accelerate regulatory submissions and enable companion diagnostic commercialization.
Genetic Factors in Drug-Induced Liver Injury Click to view more details →
Real-Time Genetic Monitoring Software for Post-Market DILI Surveillance Systems
A cloud-based platform that aggregates patient genetic data with clinical outcomes to detect emerging DILI genetic risk patterns in post-market drug populations. Creates recurring revenue through enterprise subscriptions while reducing liability exposure and enabling proactive safety communications for pharmaceutical manufacturers.
Genetic Factors in Drug-Induced Liver Injury Click to view more details →
Personalized Drug-Gene Interaction Report Generator for Clinical Decision Support
A clinical decision support tool that generates patient-specific reports on genetic interactions affecting hepatotoxicity risk for prescribed medications. Monetizes through healthcare provider subscriptions, pharmacy integrations, and data analytics licensing while improving medication safety outcomes and reducing liver-related hospitalizations.
Genetic Factors in Drug-Induced Liver Injury Click to view more details →
Haploinsufficiency of TF Genes in Development
Studying how loss of single copies of transcription factor genes causes developmental disorders through dosage-sensitive gene regulation mechanisms.
Transcription Factor Genetics in Disease Click to view more details →
Dominant Negative TF Mutations in Disease
Characterizing dominant negative transcription factor mutations that interfere with wild-type protein function for understanding their unique pathomechanisms.
Transcription Factor Genetics in Disease Click to view more details →